CYC 0.59% $1.69 cyclopharm limited

Ann: SNMMI Announcement Regarding USFDA Approval of Technegas, page-6

  1. 844 Posts.
    lightbulb Created with Sketch. 118
    Surprising share price action. Bell Potter new target north of $4.

    this is one firmly in top-up territory.

    US execution should go well given the buyers (nuclear medicine departments) are on board, like they were in Canada.

    Webinar tomorrow should be the next catalyst
 
watchlist Created with Sketch. Add CYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.